Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-09-02
2008-11-04
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S077000, C544S125000, C544S333000, C544S336000, C544S361000, C514S232800, C514S253030, C514S256000
Reexamination Certificate
active
07446110
ABSTRACT:
Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner. These compounds are useful in the enhancement of weakened muscle tone and the treatment of conditions caused by androgen deficiency or which can be ameliorated by androgen administration, including osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, bone fracture, bone damage following bone reconstructive surgery, sarcopenia, frailty, aging skin, male hypogonadism, postmenopausal symptoms in women, atherosclerosis, hypercholesterolemia, hyperlipidemia, obesity, aplastic anemia and other hematopoietic disorders, inflammatory arthritis and joint repair, HIV-wasting, prostate cancer, benign prostatic hyperplasia (BPH), abdominal adiposity, metabolic syndrome, type II diabetes, cancer cachexia, Alzheimer's disease, muscular dystrophies, cognitive decline, sexual dysfunction, sleep apnea, depression, premature ovarian failure, and autoimmune disease, alone or in combination with other active agents.
REFERENCES:
patent: 4377584 (1983-03-01), Rasmusson et al.
patent: 5237065 (1993-08-01), Holt et al.
patent: 5407939 (1995-04-01), Panzeri et al.
patent: 5418238 (1995-05-01), Panzeri et al.
patent: 5510351 (1996-04-01), Graham et al.
patent: 5525608 (1996-06-01), Adams et al.
patent: 5693809 (1997-12-01), Durette et al.
patent: 5710275 (1998-01-01), Bakshi et al.
Rasmusson, G. et al., J. Med. Chem., 2986, vol. 29, pp. 2298-2315.
Kaufman Mildred L.
Meissner Robert S.
Mitchell Helen J.
Aulakh Charanjit S
Camara Valerie J.
Merck & Co. , Inc.
Panzer Curtis C.
LandOfFree
17-Heterocyclic-4-azasteroid derivatives as androgen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 17-Heterocyclic-4-azasteroid derivatives as androgen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17-Heterocyclic-4-azasteroid derivatives as androgen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4043718